Identification of Drug Targets in Breast Cancer Metabolic Network

Krishna Kanhaiya1,2, Dwitiya Tyagi-Tiwari1,2

  • 1Computational Biomodeling Laboratory, Turku Centre for Computer Science, Turku, Finland.

Insights

Identifying effective drug targets in breast cancer metabolism is challenging. This study used network analysis to find key enzymes (high degree nodes) and proteins crucial for targeting cancer, paving the way for new therapeutics.

Area of Science:

  • Metabolic Engineering
  • Computational Biology
  • Cancer Research

Background:

  • Genome-scale metabolic models aid in understanding cancer.
  • Identifying effective metabolic drug targets (DTs) for small-molecule compounds remains a challenge.

Purpose of the Study:

  • To identify effective drug targets for breast cancer using network analysis of metabolic models.
  • To investigate the role of enzyme-centric networks in cancer progression.

Main Methods:

  • Network analysis of enzyme-centric metabolic models.
  • Identification of high degree nodes (HDNs) as key drivers.
  • Correlation and principal component analysis to identify significant proteins.

Main Results:

  • High degree nodes (HDNs) in metabolic networks are critical for cancer progression.
  • Specific proteins were identified as potential effective drug targets.
  • These proteins activate target metabolites by stimulating enzyme active sites.

Conclusions:

  • Network analysis of metabolic models offers a valuable approach for drug target identification.
  • Statistical modeling of metabolic networks can lead to effective therapeutic strategies.
  • This approach supports the development of personalized medicine for cancer treatment.

Related Concept Videos

Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
3.8K